| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |